Patents by Inventor Peter Leskovar

Peter Leskovar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunological Methods of Treating Cancer
    Publication number: 20070231326
    Abstract: A drug, affecting the hyperactivated immunologic effector cells, comprising (I) a Ca-antagonist and (II) an agent, reducing the intracellular cAMP/cGMP-ratio, is being described. In addition, a drug, affecting the hyperactivated immunologic effector cells, consisting of (I) an agent, eliminating the hyperactivated effector cells and (II) alloreactive cells with predetermined cell death, is being described.
    Type: Application
    Filed: May 17, 2007
    Publication date: October 4, 2007
    Inventor: Peter Leskovar
  • Immunological methods of treating cancer
    Publication number: 20040053832
    Abstract: A drug, affecting the hyperactivated immunologic effector cells, comprising (I) a Ca-antagonist and (II) an agent, reducing the intracellular cAMP/cGMP-ratio, is being described. In addition, a drug, affecting the hyperactivated immunologic effector cells, consisting of (I) an agent, eliminating the hyperactivated effector cells and (II) alloreactive cells with predetermined cell death, is being described.
    Type: Application
    Filed: April 2, 2003
    Publication date: March 18, 2004
    Inventor: Peter Leskovar
  • Drugs and methods for treating cancer
    Publication number: 20020094542
    Abstract: A drug is described, containing, in addition to usual carriers-substances, adjuvants and/or additives—a component A, eliminating suppressor-T-cells in a specific or non-specific way, and a component B, activating effector cells. Also provided by the present invention is a method of treating cancer comprising eliminating suppressor cells in the subject, preactivating lymphocytes from the subject ex vivo, and injecting the preactivated lymphocytes into the subject, thereby treating the cancer.
    Type: Application
    Filed: March 1, 2002
    Publication date: July 18, 2002
    Inventor: Peter Leskovar
  • Agents, affecting the hyperactivated immunological effector cells
    Patent number: 6156312
    Abstract: A method to reduce hyperactivated immunologic effector cells involves the administration (I) a Ca-antagonist and (II) an agent, to reduce the intracellular cAMP/cGMP-ratio. A treatment for eliminating the hyperactivated effector cells utilizes a combination of an agent to eliminate the hyperactivated effector cells and alloreactive cells with predetermined cell death.
    Type: Grant
    Filed: January 18, 1996
    Date of Patent: December 5, 2000
    Inventor: Peter Leskovar
  • Thick-layer conductor path pastes
    Patent number: 4039721
    Abstract: A thick-layer conductor path paste consisting of a suspension of a powder mixture containing metals and fritted glass in an organic carrier medium. Also, methods for making conductor paths and the paths so made.
    Type: Grant
    Filed: September 9, 1975
    Date of Patent: August 2, 1977
    Assignee: Siemens Aktiengesellschaft
    Inventors: Artur Weitze, Peter Leskovar